A subset of patients with BP has autoantibodies targeting regions of BP180 outside the NC16A domain, often presenting with milder disease severity and fewer erythema than typical BP cases with anti-BP180 NC16A autoantibodies. The gene discussed is COL17A1; the disease is Erythema.